FamiCord AG (ETR:V3V)

Market Cap	86.46M
Revenue (ttm)	85.71M
Net Income (ttm)	-12.02M
Shares Out	17.43M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	864.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	338
Average Volume	2,774
Open	4.94
Previous Close	4.96
Day's Range	4.94 - 5.00
52-Week Range	3.70 - 5.10
Beta	0.62
RSI	66.53
Earnings Date	Aug 27, 2025

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 771
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: V3V

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.